India’s weight-loss drugs to get cheaper as semaglutide patent expires

Affordable generic versions of popular weight-loss drugs Wegovy and Ozempic are set to launch in India. This follows the patent expiry of semaglutide, the key ingredient. Several Indian pharmaceutical companies are preparing for a March 21 launch.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/GcepZab
via IFTTT